Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 297-854-1 | CAS number: 93763-35-0 A complex combination of hydrocarbons obtained as solvents which have been subjected to hydrotreatment in order to convert aromatics to naphthenes by catalytic hydrogenation.
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- migrated information: read-across based on grouping of substances (category approach)
- Adequacy of study:
- key study
- Study period:
- 1990-08-29 to 1992-03-10
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: This study is classified as reliable without restriction because it was conducted according to EPA OTS 798.4100.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 992
- Report date:
- 1992
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- EPA OTS 798.4100 (Skin Sensitisation)
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- GLP compliance:
- yes
- Type of study:
- Buehler test
- Justification for non-LLNA method:
- The first-choice method according to REACH Annex VII §8.3, the Murine Local Lymph Node Assay, is known to give false positive results with hydrocarbon substances.
Test material
- Reference substance name:
- 68333-23-3
- Cas Number:
- 68333-23-3
- IUPAC Name:
- 68333-23-3
- Reference substance name:
- Thermocracked kerosine
- IUPAC Name:
- Thermocracked kerosine
- Test material form:
- other: low viscosity liquid hydrocarbon
- Details on test material:
- - Name of test material: F-133, thermocracked kerosene, CAS No. 68333-23-3
- Substance type:
- Physical state: transparent, colourless to light yellow coloured liquid; petroleum naphtha odour
- Analytical purity: 100% petroleum hydrocarbons
- Storage condition of test material: materials were stored at temperature less than 27 degrees celsius
- Specific gravity: approximately 0.74
- Flash point: -43°C, extremely flammable
- Density: 0.8965 g/ml
- pH: 5
Constituent 1
Constituent 2
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- Hartley
- Sex:
- male
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Sasco, Inc., Omaha, Nebraska
- Age at study initiation: young adult
- Weight at study initiation: 300 to 500 grams
- Housing: individually housed in stainless steel, wire mesh bottom cages
- Diet: fresh Agway certified guinea pig feed provided ad libitum, throughout both acclimation and study periods
- Water: provided ad libitum via automatic watering system
- Acclimation period: 14 days for induction phase animals; 7 days for dose selections phase animals
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 17 to 26 degrees celsius
- Humidity (%): 40 to 70%
- Air changes (per hr): no less than ten changes per hour
- Photoperiod (hrs dark / hrs light): 12 hours light/ 12 hours dark
IN-LIFE DATES: From: 1990-08-29 To: 1990-10-12
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- epicutaneous, occlusive
- Vehicle:
- other: Mineral oil
- Concentration / amount:
- Of test substance at:
Dose selection (irritation) phase: undiluted F-133, 1:2 v/v, 1:4 v/v, and 1:8 v/v F-133
Induction phase: undiluted
Challenge phase: 1:4 v/v
Challengeopen allclose all
- Route:
- epicutaneous, occlusive
- Vehicle:
- other: Mineral oil
- Concentration / amount:
- Of test substance at:
Dose selection (irritation) phase: undiluted F-133, 1:2 v/v, 1:4 v/v, and 1:8 v/v F-133
Induction phase: undiluted
Challenge phase: 1:4 v/v
- No. of animals per dose:
- Of test substance at:
Dose selection phase: six animals
Induction phase and challenge phase: ten animals - Details on study design:
- RANGE FINDING TESTS: Six guinea pigs were used for the dose selection phase. Each animal was dosed with either undiluted, or 1:2 v/v, 1:4 v/v,
or 1:8 v/v mineral oil dilutions. The respective dilutions were applied to four pads, placed on the shaved areas, and occlusively wrapped. the
wrappings were removed after six hours and the skin was scored using the Draize method after 24 hours.
MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: three
- Exposure period: 6 hours
- Test groups: one group of ten guinea pigs dosed with 0.5 ml of undiluted F-133
- Control group: one group of 10 guinea pigs were dosed with 0.3% DNCB in 80% ethanol/water and served as the positive control;
one group of 4 guinea pigs were dosed with 0.5 mL of undiluted test substance to serve as the challenge control; one group of 4 guinea pigs
were dosed with mineral oil to serve as the vehicle control group
- Site: shaved strip of hair along one side of the dorsal midline
- Frequency of applications: one 6 hour exposure per week
- Duration: 3 weeks
- Concentrations: undiluted test article
B. CHALLENGE EXPOSURE
- No. of exposures: one
- Day(s) of challenge: the challenge phase took place 14 days following the last induction application
- Exposure period: 6 hours
- Test groups: the induction/challenge group consists of 10 guinea pigs dosed with a 1:4 F-133 dilution of the test article
- Control group: four guinea pigs treated with 1:4 dilution of F-133 in mineral oil as challenge control, ten guinea pigs treated with 0.2% DNCB in 80% ethanol/water as induction/ challenge positive control, four guinea pigs treated with 0.2% DNCB in 80% ethanol/water as challenge control,
four guinea pigs in the mineral oil as vehicle control
- Site: shaved strip of hair along one side of the dorsal midline on the opposite side from the induction test site.
- Concentrations: 1:4 dilution of F-133
- Evaluation (hr after challenge): 24 and 48 hours after exposure
- Challenge controls:
- 1:4 dilution of F-133 challenge control; 0.2% DNCB challenge control
- Positive control substance(s):
- yes
- Remarks:
- 1,4 dinitrochlorobenzene (2,4 DNCB)
Study design: in vivo (LLNA)
- Statistics:
- Response grade, severity index, and incidence were generated for each treatment period. The response grade is the sum of the erythema and edema scores based on the standard Draize scoring system. The severity index is the sum of all response grades at 24 and 48 hours, multiplied by the number of animals with that given response grade, divided by the number of animals in the group. The incidence is the number of animals exhibiting a response grade of one or more at either 24 or 48 hours.
Results and discussion
- Positive control results:
- DNCB induced an appropriate positive response in the induction and challenge phases and is considered a delayed contact sensitizer, under the conditions of this test.
In vivo (non-LLNA)
Resultsopen allclose all
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 1:4 dilution
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- Severity Index (erythema + oedema) = 0.0
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 1:4 dilution. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: Severity Index (erythema + oedema) = 0.0.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 1:4 dilution
- No. with + reactions:
- 0
- Total no. in group:
- 4
- Clinical observations:
- Severity Index (erythema + oedema) = 0.0
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: 1:4 dilution. No with. + reactions: 0.0. Total no. in groups: 4.0. Clinical observations: Severity Index (erythema + oedema) = 0.0.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- positive control
- Dose level:
- 0.2%
- No. with + reactions:
- 10
- Total no. in group:
- 10
- Clinical observations:
- Severity Index (erythema + oedema) = 3.8
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: positive control. Dose level: 0.2%. No with. + reactions: 10.0. Total no. in groups: 10.0. Clinical observations: Severity Index (erythema + oedema) = 3.8.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 1:4 dilution
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- Severity Index (erythema + oedema) = 0.0
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 1:4 dilution. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: Severity Index (erythema + oedema) = 0.0.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 1:4 dilution
- No. with + reactions:
- 0
- Total no. in group:
- 4
- Clinical observations:
- Severity Index (erythema + oedema) = 0.0
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: negative control. Dose level: 1:4 dilution. No with. + reactions: 0.0. Total no. in groups: 4.0. Clinical observations: Severity Index (erythema + oedema) = 0.0.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- positive control
- Dose level:
- 0.2%
- No. with + reactions:
- 10
- Total no. in group:
- 10
- Clinical observations:
- Severity Index (erythema + oedema) = 3.0
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: positive control. Dose level: 0.2%. No with. + reactions: 10.0. Total no. in groups: 10.0. Clinical observations: Severity Index (erythema + oedema) = 3.0.
Any other information on results incl. tables
The
scores after the challenge treatment are summarised below
Group |
Time |
Response Grade Range |
Incidence |
F-133 Induction/Challenge group |
24 h |
0 |
0/10 |
|
48 h |
0 |
0/10 |
F-133 Challenge control |
24 h |
0 |
0/4 |
|
48 h |
0 |
0/4 |
DNCB Induction/Challenge positive control |
24 h |
3-5 |
10/10 |
|
48 h |
2-4 |
10/10 |
DNCB Challenge control |
24 h |
0-1 |
3/4 |
|
48 h |
0-1 |
3/4 |
Vehicle control |
24 h |
0 |
0/4 |
|
48 h |
0 |
0/4 |
On
the basis of the above response, the test material was not sensitizing.
No. with positive reactions:
Induction Phase:
Treatment 1 Scores: 9 out of 10 (test group); dose: 0.5 ml of undiluted F-133
Treatment 1 Scores: 9 out of 10 (positive control); dose: 0.5 ml of 0.3% DNCB
Treatment 2 Scores: 10 out of 10 (test group); dose: 0.5 ml of undiluted F-133
Treatment 2 Scores: 10 out of 10 (positive control); dose: 0.5 ml of 0.3% DNCB
Treatment 3 Scores: 10 out of 10 (test group); dose: 0.5 ml of undiluted F-133
Treatment 3 Scores: 10 out of 10 (positive control); dose: 0.5 ml of 0.3% DNCB
Challenge Scores:
0 out of 10 (Induction/Challenge test group); dose: 0.5 ml of F-133 1:4 dilution in mineral oil
0 out of 4 (F-133 Challenge Control); dose: 0.5 ml of F-133 1:4 dilution in mineral oil
10 out of 10 (DNCB Induction/Challenge Group); dose: 0.5 ml of 0.3% DNCB in 80% ethanol
3 out of 4 (DNCB Challenge Control); dose: 0.5 ml of 0.2% DNCB in 80% ethanol
0 out of 4 (Vehicle Challenge Control); dose: 0.5 ml of mineral oil
Applicant's summary and conclusion
- Interpretation of results:
- not sensitising
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- During the challenge phase, exposure of a 1:4 dilution of thermocracked kerosine to induction phase test animals did not yield higher response grades, severity, or incidence than those associated with the naive challenge control group exposed to thermocracked kerosine.
During the challenge phase, exposure of 0.2% DNCB to induction phase positive control animals elicited significantly higher response grades, severity indices, and incidence over the naive DNCB challenge control group. This indicates an appropriate positive response.
The vehicle irritation control group was free of dermal irritation during the challenge phase therefore, mineral oil used as a dilutant is not an irritant.
Therefore, under the conditions of this study, F-133 is not considered a delayed contact sensitizer. - Executive summary:
In a dermal sensitisation study using thermocracked kerosine in mineral oil, male young adult Pig/Hartley guinea pigs were tested using a modified Buehler technique.
During the challenge phase, a second exposure of a 1:4 dilution of thermocracked kerosine to induction test animals did not yield higher response grades, severity, or incidence than those associated with the naive challenge control group exposed to thermocracked kerosine. During the challenge phase, exposure of 0.2% DNCB to induction positive control animals elicited significantly higher response grades, severity indices, and incidence over the naive DNCB challenge control group. The vehicle irritation control group was free of dermal irritation during the challenge phase. Therefore, under the conditions of this study, thermocracked kerosine is not considered a delayed contact sensitiser and DNCB induced an appropriate positive response.
This study received a Klimisch score of 1 and is classified as reliable without restriction because it was conducted according to EPA OTS 798.4100.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.